FASCINATE-2 topline data: Denifanstat surpasses placebo for NASH with fibrosis at week 52
Topline data from the phase 2b FASCINATE-2 trial showed “statistically significant improvement” for denifanstat in biopsy-confirmed nonalcoholic steatohepatitis with stage 2 or stage 3 fibrosis at 52...
healio.com